Live Breaking News & Updates on Baseline Laxative Use|Page 1

Stay updated with breaking news from Baseline laxative use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Salix Pharmacetuicals Will Present Scientific Data Featuring Post Hoc Analyses For RELISTOR® (Methylnaltrexone Bromide) At ASRA's 46th Annual Spring Meeting


Salix Pharmacetuicals Will Present Scientific Data Featuring Post Hoc Analyses For RELISTOR® (Methylnaltrexone Bromide) At ASRA s 46th Annual Spring Meeting
News provided by
Share this article
Share this article
BRIDGEWATER, N.J., May 13, 2021 /PRNewswire/  Salix Pharmaceuticals ( Salix ), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today announced that two RELISTOR® (methylnaltrexone bromide) scientific posters will be presented at the 46th Annual Regional Anesthesiology and Acute Pain Medicine Meeting being held May 13 – 15, 2021. The meeting is hosted by The American Society of Regional Anesthesia and Pain Medicine (ASRA).
The following posters will be presented on Thursday, May 13 from 10:30 a.m. – 12:00 p.m. ET: ....

Nova Scotia , United States , New Jersey , Qit Yu , Lynnr Webster , Bausch Health Companies Inc , American Society Of Regional Anesthesia , Salix Pharmaceuticals , Exchange Commission , Bausch Health , Annual Regional Anesthesiology , Acute Pain Medicine Meeting , American Society , Regional Anesthesia , Pain Medicine , Advanced Illness , Opioid Induced Constipation , Baseline Laxative Use , Child Pugh Class , Prescribing Information , Bausch Health Companies , Canadian Securities Administrators , பாலம் நீர் , நோவா ஸ்கோடியா , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜெர்சி ,